Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1305, 2001-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Linezolid lower-cost option for cellulitis in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. :
Apixaban most cost effective option in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 635, 2011-01 ,pp. :
Demand for low-cost antiretrovirals continues
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 330, 2001-01 ,pp. :
Linezolid best value option for VAP in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
WHO's low-cost strategies to prevent noncommunicable diseases
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 638, 2011-01 ,pp. :